Mibefradil in the treatment of systemic hypertension: comparative studies with other calcium antagonists.

Massie, B M; Lacourcière, Y; Viskoper, R; Woittiez, A; Kobrin, I

Massie, B M; Lacourcière, Y; Viskoper, R; Woittiez, A; Kobrin, I.

Affiliation

Massie BM; University of California, San Francisco, USA.

Am J Cardiol ; 80(4B): 27C-33C, 1997 Aug 21.

Article in En | MEDLINE | ID: mdl-9286851

Subject(s)

Amlodipine/therapeutic use; Benzimidazoles/therapeutic use; Calcium Channel Blockers/therapeutic use; Diltiazem/therapeutic use; Hypertension/drug therapy; Nifedipine/therapeutic use; Tetrahydronaphthalenes/therapeutic use; Adult; Aged; Amlodipine/adverse effects; Amlodipine/pharmacology; Benzimidazoles/pharmacology; Calcium Channel Blockers/adverse effects; Calcium Channel Blockers/pharmacology; Diltiazem/adverse effects; Diltiazem/pharmacology; Double-Blind Method; Edema/chemically induced; Female; Heart Rate/drug effects; Hemodynamics/drug effects; Humans; Leg; Male; Mibefradil; Middle Aged; Nifedipine/adverse effects; Nifedipine/pharmacology; Tetrahydronaphthalenes/pharmacology

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Tetrahydronaphthalenes / Benzimidazoles / Calcium Channel Blockers / Diltiazem / Nifedipine / Amlodipine / Hypertension Type of study: Clinical_trials Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Am J Cardiol Year: 1997 Document type: Article

Search on Google

XML

PubMed Links